EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Emerging Therapeutic Innovations for Vitiligo Treatment

Weiran Li, Penghao Dong, Guiyuan Zhang, Junjie Hu, Sen Yang

Current Issues in Molecular Biology · 14.03.2025 · 47 (3) · 191

DOI: 10.3390/cimb47030191 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Current Issues in Molecular Biology, online erschienen am 14.03.2025. Verfasst von Weiran Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Dermatology and Department of Dermatology, The First Affiliated Hospital, Anhui Medical University, Hefei 230000, China. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Basic and Clinical Collaborative Research Program of Anhui Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vitiligo is a chronic autoimmune disorder with a multifactorial etiology, typically manifesting as localized or generalized hypopigmentation or depigmentation of the skin and mucous membranes. The pathogenesis of vitiligo is complex and significantly impacts patients’ quality of life. Although traditional treatments such as hormone therapy, topical medications, and laser therapy can help control the disease to some extent, their outcomes remain unsatisfactory. Therefore, ongoing research is crucial to explore and develop novel treatment strategies while assessing their efficacy and safety. This review aims to classify and summarize various new candidate drugs for vitiligo currently undergoing clinical trials, providing a reference for clinical practice. Recent advancements in the understanding of the pathogenesis of vitiligo have facilitated the development of potential treatment strategies, such as Janus kinase inhibitors, cytokine blockers, and agents targeting tissue-resident memory or regulatory T cells. These emerging therapies offer hope to patients with vitiligo, though further investigation is needed to confirm their safety, efficacy, and optimal treatment regimens.

Schlagwörter

Stichwörter der Autor:innen

JAK inhibitorsemerging drugsimmunotherapypathogenesisvitiligo

Autor:innen und Institutionen

  • Institute of Dermatology and Department of Dermatology, The First Affiliated Hospital, Anhui Medical University, Hefei 230000, China.
  • Department of Dermatology, Dushu Lake Hospital Affiliated to Soochow University, Suzhou 215128, China.
  • Key Laboratory of Dermatology, Ministry of Education of the People's Republic of China, Hefei 230000, China.

Förderung

  • The Basic and Clinical Collaborative Research Program of Anhui Medical University

Zitieren

APA

Li, W., Dong, P., Zhang, G., Hu, J., & Yang, S. (2025). Emerging Therapeutic Innovations for Vitiligo Treatment. Current Issues in Molecular Biology, 47(3), 191. https://doi.org/10.3390/cimb47030191

Vancouver

Li W, Dong P, Zhang G, Hu J, Yang S. Emerging Therapeutic Innovations for Vitiligo Treatment. Current Issues in Molecular Biology. 2025;47(3):191. doi:10.3390/cimb47030191

BibTeX
@article{Li2025,
  author = {Li, Weiran and Dong, Penghao and Zhang, Guiyuan and Hu, Junjie and Yang, Sen},
  title = {Emerging Therapeutic Innovations for Vitiligo Treatment},
  journal = {Current Issues in Molecular Biology},
  year = {2025},
  volume = {47},
  number = {3},
  pages = {191},
  doi = {10.3390/cimb47030191}
}
Kostenlos starten →